MIRAGEN THERAPEUTICS, INC. Uncategorized Contracts & Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Open Market Sale Agreement between Viridian Therapeutics, Inc. and Jefferies LLC (March 2025)
Equity Distribution Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2025
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2025
Indemnity Agreement between Viridian Therapeutics, Inc. and Indemnitee
Indemnification Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2024
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2024
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2023
Open Market Sale Agreement between Viridian Therapeutics, Inc. and Jefferies LLC (April 2021)
Equity Distribution Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2021
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Registration Rights Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2021
Amendment No. 10 to Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
Modification Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Deferral Agreement between Miragen Therapeutics, Inc. and Silicon Valley Bank dated April 6, 2020
Modification Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
CA
2020
Amendment No. 9 to FDP Research Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
Collaboration Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Description of Miragen Therapeutics, Inc. Common Stock and Warrants Registered Under Section 12 of the Exchange Act
Stock Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2020
Amendment No. 8 to FDP Research Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
Collaboration Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2019
Amendment No. 3 to Research Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
Collaboration Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2017
Second Addendum to Lease Agreement between Crestview, LLC and Miragen Therapeutics, Inc.
Lease Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
First Addendum to Lease Agreement between Crestview, LLC and Miragen Therapeutics, Inc. (February 18, 2015)
Lease Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Lease Agreement Between University of Arkansas for Medical Sciences and Signal Genetics, Inc. for BioVentures Building Premises
Lease Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Unsecured Demand Promissory Note between Signal Genetics, Inc. and Bennett LeBow dated March 6, 2015
Note Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2015
Amended and Restated Secured Demand Promissory Note between Signal Genetics LLC, Myeloma Health LLC, Respira Health LLC, CC Health LLC, and LeBow Alpha LLLP
Note Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2014
Consulting Agreement between Viridian Therapeutics, Inc. and William S. Marshall, Ph.D.
Consulting Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2021
Amendment No. 7 to Research Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2019
Subcontract Agreement Between Yale University and MiRagen Therapeutics, Inc. for NIH Grant Research on promiR-29
Services Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Signal Genetics, Inc. Non-Employee Director Cash and Equity Compensation Policy
Compensation Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Indemnity Agreement between Miragen Therapeutics, Inc. and Indemnitee (2016)
Indemnification Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
Support Agreement between Miragen Therapeutics, Inc. and Signal Genetics, Inc. Stockholder (October 31, 2016)
Voting Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
Support Agreement between Signal Genetics, Inc. and Miragen Therapeutics, Inc. Stockholder (October 31, 2016)
Voting Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
DE
2016
Amendment to Employment and Incentive Units Agreements between Signal Genetics, LLC and Samuel D. Riccitelli
Modification Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014